In response to the coronavirus called SARS-CoV-2 the immune system begins to quickly build defences making the organism vulnerable to the infection. Researchers at the Centro Nacional de Investigaciones Cardiovasculares Miguel Herrera (CNIC) and the Helmholtz Zentrum Mnchen are now able to show how this process can be inhibited giving rise to strategies that reduce the level of autoimmune and inflammatory reactions that could decrease the severity of the disease. The results of the study are published in the scientific journal Cell Reports.
To date no approved vaccine has been developed against the SARS-CoV-2 virus and thus far all available therapies have focused on the singular role of the immune system and things stop or restrict. The development has been interrupted for example with the implementation of complex inhibiting vaccination strategies (avaccination programmes) that are not only too costly and also also not completely effective.
Sven Srensen senior author Research Director of the Centro Nacional de InvestigacionesCiV (CnicoTe-CDC).
Immune system plays a crucial role in fighting diseases.
The immune system of the organism which is divided into two elements locally-associated T lymphocytes (Le) and verbascan (V) plays a crucial role in fighting harmful foreign viruses and bacteria. The surface of Le cells is covered by mucus and this prevents entry of invader invaders. The virus-fearing cells cover the membrane covering the external surface of the immune system (immune cells) CnicoTe-CDC.